Rare syndromes of the head and face: mandibulofacial and acrofacial dysostoses.
read more
Citations
Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. Vol. 279 (2004) 44475–44482
Older paternal age and fresh gene mutation: data on additional disorders
The pathogenesis of the Treacher Collins syndrome (mandibulofacial dysostosis)
Treacher Collins syndrome mutations in Saccharomyces cerevisiae destabilize RNA polymerase I and III complex integrity.
Developmental processes regulate craniofacial variation in disease and evolution.
References
p53, the Cellular Gatekeeper for Growth and Division
Mdm2 promotes the rapid degradation of p53
The neural crest
Exome sequencing identifies the cause of a Mendelian disorder
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas
Related Papers (5)
Haploinsufficiency of SF3B4, a component of the pre-mRNA spliceosomal complex, causes Nager syndrome.
Frequently Asked Questions (16)
Q2. What future works have the authors mentioned in the paper "Rare syndromes of the head and face: mandibulofacial and acrofacial dysostoses" ?
One possibility is that DHODH loss-of-function disrupts the transcriptional elongation of genes specifically required for NCC, bone and cartilage development. It is crucial that as the authors continue to investigate the developmental and disease roles for these genes and processes using animal models that they explore the possibility for interactions between each of these genes with other genes and pathways important for NCC, bone and cartilage development.
Q3. What is the underlying cause of the acrofacial dysostoses?
Differential regulation of gene expression, transcription factors or posttranslational modifications as well as the type and location of the mutation could each contribute to the underlying cause of the tissue-specific phenotypes observed in ribosomopathies and other mandibulofacial and acrofacial dysostoses.
Q4. What is the role of p53 in the development of head and facial tissues?
p53 functions as a tumor suppressor, and inhibiting p53 could potentially lead to tumorigenic side effects emphasizing the need to explore additional avenues for preventing TCS and other ribosomopathies that affect head and facial development.
Q5. What is the role of Chk2 in the cell cycle checkpoint kinase?
γH2AXpositive neuroepithelial cells were labeled with phosphorylated Chk2 (cell cycle checkpoint kinase 2), a protein that transmits the DNA damage response signal to the apoptotic pathway and caspase 3 (a marker of apoptosis).
Q6. What is the role of PolI in the nucleolus?
46 Importantly, depletion of Treacle drastically alters the localization of UBF and PolI indicating an essential role for Treacle in nucleolar retention of these two proteins, possibly by actingas a scaffold protein to maintain PolI in the nucleolus.
Q7. What is the role of ribosomes in the development of acrofa?
The elevated expression of ribosomeassociated genes in neuroepithelial cells and progenitor NCC may make them more sensitive to perturbations in ribosome biogenesis.
Q8. What is the role of ribosomes in the development of NCC?
Similar to deficient ribosome biogenesis, it is possible that the highly proliferative nature of NCC, as well as bone and cartilage progenitors makes them more susceptible to defects in mRNA splicing.
Q9. What is the role of treacle in ribosome biogenesis?
55 Treacle’s role in ribosome biogenesis has also been documented using the Y10B antibody, which recognizes epitopes of rRNA56 and is used as a marker of mature ribosomes.
Q10. What is the definition of acrofacial dysostosis?
Miller syndrome (OMIM263750), also termed postacrofacial dysostosis (POADS), Genee-Wiedemann, and Wildervanck-Smith syndromes, is classified as an acrofacial dysostosis disorder.
Q11. What type of acrofacial dysostosis was recently defined in three?
19,67 Acrofacial Dysostosis-Cincinnati type was recently defined in three affected individuals with variable phenotypes ranging from mild mandibulofacial dysostosis to more severe acrofacial dysostosis.19
Q12. What is the role of polr1a in neuroepithelial cell survival?
TUNEL assays subsequently revealed that polr1a is required for neuroepithelial cell survival and the generation of NCC but is not required for the survival of migrating NCC,19 which is similar to the established roles of Tcof1, polr1c and polr1d.
Q13. What is the role of Treacle in neuroepithelial and progenitor?
56 Homotypic transplantation of Di-labeled midbrain and hindbrain tissue demonstrated that Treacle functions cellautonomously to promote neuroepithelial and progenitor NCC proliferation and survival through dynamic regulation of the spatiotemporal productionof mature ribosomes in neuroepithelial cells and NCC.48 Consistent with these observations, a recent study also proposed a link between Treacle and ribosome biogenesis associated factors in NCC development.
Q14. What is the reason for the decrease in NCC progenitors?
Consistent with this idea, translation blocking morpholino knockdown of Sf3b4 in Xenopus embryos resulted in a decrease in NCC progenitors as a consequence of cell death.
Q15. What is the role of ribosomes in acrofacial dysost?
In this scenario, core ribosome components, could act differently inspecific tissues due to their interaction with transient proteins, cis-regulatory elements or other cofactors that are present within specific subsets of mRNAs.92 Acrofacial dysostoses, such as MFDM and Nager syndrome, can arise through perturbations of global processes other than ribosome biogenesis and yet still exhibit similar defects in cranial NCC and bone and cartilage development.
Q16. What is needed to understand the mechanisms of MFDM?
To understand these mechanisms, screening for eye anomalies in MFDM patients and for craniofacial anomalies in MAC patients is needed.